Normal weight obesity (NWO) is a health condition that often goes unnoticed because it hides behind a normal body weight. People with NWO have a body mass index (BMI) within the normal range but carry excess body fat, especially around the abdomen. This post explores normal-weight obesity and MTHFR gene variants, and how these two are linked.

People with the MTHFR gene mutation often face challenges related to methylation and metabolic health. One promising area of support involves increasing levels of glucagon-like peptide-1 (GLP-1), a hormone that helps regulate blood sugar, appetite, and insulin secretion. It is possible to naturally boost GLP-1 levels for MTHFR gene mutation support and weight reduction.

GLP-1 inhibitors have gained attention in recent years for their role in managing blood sugar levels and supporting weight loss. But what exactly is GLP-1, how do these inhibitors work in the body, and what happens when they interact with genetic factors like the MTHFR gene variance? This article breaks down these questions with clear explanations and insights from peer-reviewed research.